Outlook Therapeutics Inc (OTLK)

[Mionaer1]

I like your optimism. But we don't even have the results of Norse 8 yet, let alone FDA approval. Furthermore, a price of $500 per injection in Europe is completely unrealistic. Take a look at the European prices of the competitors in the OTLK presentation. A maximum of $300 in Europe is realistic.
My best case scenario: 67% of off label Bavi injections (6.3m x 0.67 = 4.22m) at $400 (USA: $500, Europe: $300) per injections results in annual sales of $1.7B.

OTLK is a one trick pony therefore a multiple of 3. So a MC of $5.1B, means a PPS of $127.5 with O/S of 40M.
Hopefully no major capital increase will be necessary in 1Q 2025, as indicated by Thermo.